Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cansu Cimen Bozkus

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Nature Reviews. Immunology|July 9, 2020
SARS-CoV-2-specific T cells without antibodiesCansu Cimen Bozkus
Nature Reviews. Immunology|September 3, 2020
Long-lasting SARS-CoV-2-specific T cell memoriesCansu Cimen Bozkus
Cancer Cell|September 3, 2021
Tumor organoid-originated biomarkers predict immune response to PD-1 blockadeCansu Cimen Bozkus, Nina Bhardwaj
The Journal of Clinical Investigation|September 17, 2024
Checkpoint therapy in cancer treatment: progress, challenges, and future directionsMesude Bicak, Cansu Cimen Bozkus, Nina Bhardwaj
Cell Reports. Medicine|January 23, 2026
Pipe dream to pipeline: Journey of cancer vaccines and the road aheadSayali Onkar, Cansu Cimen Bozkus, Mansi Saxena, et al.
Frontiers in Immunology|July 26, 2023
Immune escape and resistance to immunotherapy in mismatch repair deficient tumorsGuillaume Mestrallet, Matthew Brown, Cansu Cimen Bozkus, et al.
STAR Protocols|August 30, 2021
A T-cell-based immunogenicity protocol for evaluating human antigen-specific responsesCansu Cimen Bozkus, Ana Belen Blazquez, Tomohiro Enokida, et al.
Frontiers in Immunology|October 11, 2021
Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer VaccinesVladimir Roudko, Cansu Cimen Bozkus, Benjamin Greenbaum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2015
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell ImmunityCansu Cimen Bozkus, Bennett D Elzey, Scott A Crist, et al.
Cancer Discovery|July 4, 2019
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative NeoplasmsCansu Cimen Bozkus, Vladimir Roudko, John P Finnigan, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Nature Reviews. Immunology|July 9, 2020
SARS-CoV-2-specific T cells without antibodiesCansu Cimen Bozkus
Nature Reviews. Immunology|September 3, 2020
Long-lasting SARS-CoV-2-specific T cell memoriesCansu Cimen Bozkus
Cancer Cell|September 3, 2021
Tumor organoid-originated biomarkers predict immune response to PD-1 blockadeCansu Cimen Bozkus, Nina Bhardwaj
The Journal of Clinical Investigation|September 17, 2024
Checkpoint therapy in cancer treatment: progress, challenges, and future directionsMesude Bicak, Cansu Cimen Bozkus, Nina Bhardwaj
Cell Reports. Medicine|January 23, 2026
Pipe dream to pipeline: Journey of cancer vaccines and the road aheadSayali Onkar, Cansu Cimen Bozkus, Mansi Saxena, et al.
Frontiers in Immunology|July 26, 2023
Immune escape and resistance to immunotherapy in mismatch repair deficient tumorsGuillaume Mestrallet, Matthew Brown, Cansu Cimen Bozkus, et al.
STAR Protocols|August 30, 2021
A T-cell-based immunogenicity protocol for evaluating human antigen-specific responsesCansu Cimen Bozkus, Ana Belen Blazquez, Tomohiro Enokida, et al.
Frontiers in Immunology|October 11, 2021
Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer VaccinesVladimir Roudko, Cansu Cimen Bozkus, Benjamin Greenbaum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2015
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell ImmunityCansu Cimen Bozkus, Bennett D Elzey, Scott A Crist, et al.
Cancer Discovery|July 4, 2019
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative NeoplasmsCansu Cimen Bozkus, Vladimir Roudko, John P Finnigan, et al.
Pageof 3